Recombinant FGFR2 (Bemarituzumab Biosimilar) antibody

Catalog No. ABIN7795054

This anti-FGFR2 (Bemarituzumab Biosimilar) antibody is a Humanized Monoclonal antibody detecting FGFR2 (Bemarituzumab Biosimilar) in ELISA. Suitable for Human.

Quick Overview for Recombinant FGFR2 (Bemarituzumab Biosimilar) antibody (ABIN7795054)

Target: FGFR2 (Bemarituzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This FGFR2 (Bemarituzumab Biosimilar) antibody is un-conjugated

Application: ELISA

Product Details anti-FGFR2 (Bemarituzumab Biosimilar) Antibody

Purpose: Anti-FGFR2(bemarituzumab biosimilar) mAb

Isotype: IgG1 kappa

Application Details

Application Notes: ELISA 1:5000-10000

Restrictions: For Research Use only

Handling

Format: Lyophilized

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized antibodies are shipped at ambient temperature.

Target Details for FGFR2 (Bemarituzumab Biosimilar)

Target: FGFR2 (Bemarituzumab Biosimilar)

Alternative Name: bemarituzumab biosimilar

Target Type: Biosimilar

Background: FPA-144, FPA144, FPA114-A,BEK, KGFR, KSAM

UniProt: P21802